XML 49 R38.htm IDEA: XBRL DOCUMENT v3.4.0.3
SEGMENT INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profit for the three-month periods ended March 31, 2016 and 2015 were as follows:
 
Three Months Ended
March 31,
 
2016
 
2015
(restated)
Revenues:
 
 
 
Developed Markets(1)
$
1,929.9

 
$
1,743.6

Emerging Markets(2)
441.7

 
426.5

Total revenues
2,371.6

 
2,170.1

 
 
 
 
Segment profit:
 
 
 
Developed Markets(3)
259.6

 
667.7

Emerging Markets(4)
18.3

 
54.6

Total segment profit
277.9

 
722.3

 
 
 
 
Corporate(5)
(146.4
)
 
(69.2
)
Restructuring, integration and other costs
(38.0
)
 
(55.0
)
Acquisition-related costs
(1.8
)
 
(13.9
)
Acquisition-related contingent consideration
(2.4
)
 
(7.1
)
Other expense
(23.1
)
 
(6.1
)
Operating income
66.2

 
571.0

Interest income
0.9

 
0.9

Interest expense
(426.6
)
 
(297.8
)
Loss on extinguishment of debt
—

 
(20.0
)
Foreign exchange and other
(6.2
)
 
(71.1
)
(Loss) income before provision for income taxes
$
(365.7
)
 
$
183.0

____________________________________
(1)
Developed Markets segment revenues reflect incremental product sales revenue in the three-month period ended March 31, 2016 from 2015 acquisitions of $513 million, in the aggregate, primarily from the Salix Acquisition and the acquisition of certain assets of Dendreon.
(2)
Emerging Markets segment revenues reflect incremental product sales revenue in the three-month period ended March 31, 2016 from 2015 acquisitions of $59 million, in the aggregate, primarily from the Amoun Acquisition.
(3)
Developed Markets segment profit in the three-month period ended March 31, 2016 reflects the impact of acquisition accounting adjustments related to the fair value adjustments to inventory and identifiable intangible assets of $637 million, in the aggregate, primarily from the Salix Acquisition, compared with $314 million in the corresponding period of 2015.
(4)
Emerging Markets segment profit in the three-month period ended March 31, 2016 reflects the impact of acquisition accounting adjustments related to the fair value adjustments to inventory and identifiable intangible assets of $86 million, in the aggregate, compared with $76 million in the corresponding period of 2015.
(5)
Corporate reflects non-restructuring-related share-based compensation expense of $50 million in the three-month period ended March 31, 2016, compared with $24 million in the corresponding period of 2015. The expense in the three-month period ended March 31, 2016, included a charge relating to the acceleration of vesting of the performance-based RSUs held by the Company's former Chief Executive Officer. See Note 11 for additional information.
Schedule of total assets by segment
Total assets by segment as of March 31, 2016 and December 31, 2015 were as follows:
 
As of
March 31,
2016
 
As of
December 31,
2015
Assets:
 
 
 
Developed Markets
$
40,580.6

 
$
41,182.7

Emerging Markets
6,861.5

 
6,897.4

 
47,442.1

 
48,080.1

Corporate
1,577.8

 
884.4

Total assets
$
49,019.9

 
$
48,964.5